India to United States: Clindamycin Export Trade Route

The India to United States Clindamycin corridor is one of India's established pharmaceutical export routes, with 744 shipments documented worth a combined $41.2M USD. The route is dominated by ENCUBE ETHICALS PRIVATE LIMITED, which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.

Across 20 active suppliers, the average shipment value stands at $55.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with clindamycin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 30.7%, placing it at rank #13 among India's top clindamycin export destinations globally.

On the import side, key buyers of Indian clindamycin in United States include CARDINAL HEALTH, IPD, SC, USA, AUROLOGISTICS LLC (AUROBINDO PHARMA and 57 others. CARDINAL HEALTH is the single largest importer with 88 shipments valued at $4.9M USD.

India's clindamycin exports to United States are driven primarily by a handful of large-scale manufacturers. ENCUBE ETHICALS PRIVATE LIMITED with 225 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 20 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together account for 65% of total trade value on this route. The average shipment value of $55.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as clindamycin hydrochloride capsules 300mg(clindamycin hydrochloride capsules usp300 mg) 100'snos and clindamycin hydrochloride capsules 300mg(clindamycin hydrochloride capsules usp300 mg) 100's, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CARDINAL HEALTH is the largest importer with 88 shipments worth $4.9M USD — representing 12% of all clindamycin imports from India on this route. A total of 60 buyers are active on this corridor.